“There are also mesenchymal stem cells-based approaches in the clinic today and some rather large Phase 3 trials are being finalized this year. It will be interesting to see the outcome of these!”
Great find @aquazul .... like I have said previously, @The Yankee picked the synergies with AstraZeneca earlier in the year with this post (link below)
.... and of course the CEO of AstraZeneca is in Australia at the moment so the timing is 'coincidental' with the phase 3 CHF readout due
https://hotcopper.com.au/threads/an...624717/page-182?post_id=47370207#.X9Ve89gzbIU
Phase 3 DREAM HF-1 read-out, page-274
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.000(0.00%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4602 | $1.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 3216 | 1 |
View Market Depth
| Last trade - 09.51am 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable